Table 5 Cox regression analysis for predictors of major adverse cardiovascular events at 12 months

Age (year)

1.01

0.99 to 1.03

0.15

1.01

0.98 to1.03

0.53

Male sex

1.14

0.72 to 1.83

0.57

1.80

0.96 to 3.38

0.07

Hypertension

1.02

0.68 to 1.53

0.92

0.99

0.60 to 1.65

0.98

Hyperlipidemia

0.86

0.56 to 1.31

0.48

0.99

0.59 to 1.65

0.97

Current smoking

0.65

0.42 to 1.00

0.06

0.60

0.35 to 1.03

0.07

Waist circumference

0.98

0.95 to1.00

0.04

0.97

0.95 to 1.00

0.03

Insulin

1.82

0.74 to 4.47

0.19

1.09

0.32 to 3.73

0.89

ACEIs/ARBs use

1.12

0.73 to 1.70

0.61

0.97

0.59 to 1.59

0.44

Statin use

0.91

0.52 to 1.62

0.76

0.81

0.42 to 1.56

0.53

3-vessel disease

1.35

0.83 to 2.20

0.23

1.15

0.61 to 2.12

0.67

Drug-eluting stent

0.68

0.45 to 1.03

0.07

0.54

0.33 to 0.87

0.01

CR

0.63

0.41 to 0.96

0.03

0.75

0.43 to 1.29

0.30

Group

Non-Diabetics

1*

–

–

1*

–

–

Good-control diabetics ¹

1.06

0.53 to 2.12

0.88

1.48

0.68 to 3.21

0.32

Poor-control diabetics ²

1.59

0.96 to 2.67

0.07

2.09

1.10 to 3.95

0.02